查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916940

多孔細胞培養插入件市場（按膜材質、孔徑、插入件類型、應用和最終用戶分類）－2026-2032年全球預測

Porous Cell Culture Inserts Market by Membrane Material, Pore Size, Insert Format, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年多孔細胞培養插入物市場價值為 1.393 億美元，預計到 2026 年將成長至 1.4796 億美元，年複合成長率為 5.68%，到 2032 年將達到 2.051 億美元。

關鍵市場統計數據
基準年 2025 1.393億美元
預計年份：2026年 1.4796億美元
預測年份 2032 2.051億美元
複合年成長率 (%) 5.68%

簡要概述多孔細胞培養插入件及其在提高體外模型準確性和實驗可重複性方面日益重要的作用

多孔細胞培養插入件已成為現代生命科學實驗室的基礎工具，它們能夠建構與生理相關的細胞界面和分隔共培養系統。隨著研究團隊致力於彌合簡化的2D培養與複雜的體內生理環境之間的差距，這些插入件提供了一個模組化平台，可用於建立屏障模型、研究上皮滲透性轉運以及建立多細胞聚集體。膜工程技術的進步、幾何形狀的改進以及材料相容性的提升，拓寬了實驗設計，提高了實驗的可重複性，並使得對細胞反應的分析更加細緻入微。

材料創新、先進體外模型的監管核准以及採購方式的轉變正在重新定義買方的期望和供應商的差異化。

多孔細胞培養插入片領域正經歷一系列變革，這些變革的驅動力來自材料科學的融合發展、轉化研究的需求以及工作流程自動化。過去，插入片的選擇主要基於便利性和成本，而如今，採購者會從多個維度評估其性能，包括膜化學性質、孔結構以及與自動化液體處理平台的整合。這種以效能為導向的選擇趨勢反映了一個更大的趨勢，即實驗的精確性和實驗室間的可重複性正日益影響著採購決策。

關稅正在重塑供應鏈，迫使製造商和採購團隊優先考慮在地採購、替代貨源和業務連續性計畫。

美國的關稅環境為多孔細胞培養插入件的生產商、經銷商和最終用戶帶來了許多複雜問題，影響了成本結構和籌資策略。關稅改變了進口成品插入件與構成其組件的原料之間的相對經濟效益，導致許多企業重新評估其供應商佈局，並考慮採用近岸外包或多源採購策略來降低風險。實際上，採購團隊需要在滿足技術規格要求的同時，確保以可接受的到岸成本獲得穩定的供應。

詳細的細分揭示了膜成分、孔結構、規格配置、最終用戶需求和應用需求如何共同決定採購選擇。

仔細分析產品系列，可以發現影響購買行為和實驗結果的明顯差異。在選擇膜材料時，聚碳酸酯薄膜具有光學透明度和結構穩定性。聚對苯二甲酸乙二醇酯 (PET) 可提高某些測試的化學相容性。聚碸因其在滅菌過程中的耐久性而被選中。聚聚二氟亞乙烯)在某些應用中具有高抗蛋白結合性。這些材料的選擇通常與實驗室通訊協定中規定的測試化學、滅菌方法和成像要求一致。

區域研究活動的增加、監管多樣性和製造地分佈正在影響全球市場的需求優先事項和供應商選擇。

地理因素影響多孔插片市場的需求模式與供應考量。在美洲，製藥和生物技術公司高度位置，加上資金雄厚的學術研究中心，支撐著對符合嚴格檢驗和品質要求的高性能插片的需求。該地區還擁有大量受託研究機構(CRO)，這些組織致力於標準化基於插片的流程，以服務全球客戶，從而構建了一個有利於提供可靠文件、符合法規要求和快速響應的技術支援的供應商的生態系統。

以創新為導向的公司透過檢驗的材料、可擴展的生產流程和協作檢驗途徑來贏得要求嚴格的科研客戶的青睞，從而脫穎而出。

多孔插入材料領域的競爭格局取決於企業能否在維持產品差異化、品質保證和嚴格的材料可追溯性的同時，實現規模化生產。贏得客戶長期信賴的主要企業通常會大力投資研發，以提升膜的性能並拓展其與自動化和高內涵成像平台的兼容性。這些企業也非常重視健全的品管體系，從而能夠提供檢驗的產品，並將其整合到製藥和生物技術客戶所使用的受監管工作流程中。

為製造商和供應商提供切實可行的策略舉措，以確保韌性、檢驗績效並透過應用主導的產品交付深化客戶關係。

產業領導者應優先採取一系列切實可行的措施，以確保競爭優勢並滿足終端用戶需求。首先，透過投資獨立檢驗研究並發布應用說明，將材料特性與實驗結果連結起來，使產品開發與可驗證的檢測性能保持一致。這種以證據為基礎的方法將降低買家的抵觸情緒，並加速產品在研發和法規環境中的應用。

採用混合方法，結合關鍵相關人員訪談、同儕審查文獻回顧和迭代檢驗，確保研究結果嚴謹且具實務意義。

本分析的調查方法結合了定性和定量技術，以確保對趨勢、使用者需求和供應商行為有全面且可驗證的理解。主要研究包括對製藥和生物技術機構的實驗室主任和採購主管、受託研究機構(CRO) 的高級科學家以及製造企業的營運主管進行結構化訪談。檢驗重點關注採購標準、檢測檢驗需求、供應鏈考慮以及監管和關稅趨勢對營運的影響。

整合技術特性、供應連續性和檢驗途徑，使產品選擇與實驗目標和營運彈性保持一致。

多孔細胞培養插入片在現代生命科學工作流程中扮演著至關重要的角色，它能夠在不增加實驗室操作複雜性的前提下，實現更貼近生理實際的實驗。材料選擇、孔隙結構和規格相容性仍然是決定產品適用性的關鍵因素，而這些技術特性也越來越受到可重複性和法規遵循的評估。同時，供應鏈趨勢和關稅因素正迫使製造商和採購商重新評估其籌資策略，並在性能的同時優先考慮產品的韌性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 多孔細胞培養插入件市場（依膜材料分類）

  • 聚碳酸酯
  • 聚對苯二甲酸乙二酯
  • 聚碸
  • 聚二氟亞乙烯

9. 依孔徑分類的多孔細胞培養插入件市場

  • 0.4至3微米
    • 0.4至1微米
    • 1至3微米
  • 超過3微米
  • 小於0.4微米

10. 多孔細胞培養插入件市場（依插入件類型分類）

  • 6口井
  • 12口井
  • 24口井

第11章 多孔細胞培養插入件市場（依應用領域分類）

  • 藥物發現
    • ADME 研究
    • 高通量篩檢
  • 再生醫學
  • 毒理學

第12章 多孔細胞培養插入片市場（依最終用戶分類）

  • 學術研究機構
  • CRO（受託研究機構）
  • 製藥和生物技術公司

第13章 多孔細胞培養插入件市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 多孔細胞培養插入件市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國多孔細胞培養插入片市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國多孔細胞培養插入件市場

第17章 中國多孔細胞培養插入件市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Becton, Dickinson and Company
  • BRAND GmbH+Co KG
  • CELLTREAT Scientific Products, LLC
  • Corning Incorporated
  • Eppendorf AG
  • Greiner Bio-One International GmbH
  • Merck KGaA
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Techno Plastic Products AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-AE420CB1540A

The Porous Cell Culture Inserts Market was valued at USD 139.30 million in 2025 and is projected to grow to USD 147.96 million in 2026, with a CAGR of 5.68%, reaching USD 205.10 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 139.30 million
Estimated Year [2026] USD 147.96 million
Forecast Year [2032] USD 205.10 million
CAGR (%) 5.68%

A concise orientation to porous cell culture inserts and their expanding role in improving in vitro model fidelity and experimental reproducibility

Porous cell culture inserts have become a foundational tool in contemporary life sciences laboratories by enabling physiologically relevant cellular interfaces and compartmentalized co-culture systems. As research groups strive to bridge the gap between simplified two-dimensional cultures and complex in vivo physiology, these inserts provide a modular platform that supports barrier models, trans-epithelial transport studies, and multi-cellular assemblies. Advances in membrane engineering, format refinement, and material compatibility have expanded experimental designs, improving reproducibility and enabling more nuanced interrogation of cellular responses.

This introduction frames the broader narrative for stakeholders across research institutes, contract research organizations, and pharmaceutical and biotechnology companies who depend on reliable inserts for drug discovery, toxicology testing, and regenerative medicine research. It also outlines the technical levers that are driving adoption, including membrane porosity, chemical inertness, and mechanical stability. By situating porous inserts within current laboratory workflows and regulatory contexts, this section establishes the baseline considerations that influence procurement, assay development, and vendor selection.

The goal here is to offer a concise orientation that clarifies how the product category interacts with experimental objectives, quality control practices, and cross-disciplinary collaborations. Moving forward, the analysis will examine structural shifts in the landscape, tariff impacts, segmentation nuances, and regional dynamics that collectively shape strategic choices for users and manufacturers alike.

How materials innovation, regulatory acceptance of sophisticated in vitro models, and procurement shifts are redefining buyer expectations and supplier differentiation

The porous cell culture insert landscape is undergoing a set of transformative shifts driven by convergent advances in materials science, translational research needs, and workflow automation. Historically, inserts were selected largely on convenience and cost; today, buyers evaluate performance along multiple vectors including membrane chemistry, pore architecture, and integration with automated liquid handling platforms. This movement toward performance-driven selection reflects a larger trend in which experimental fidelity and cross-lab reproducibility exert stronger influence on procurement decisions.

Concurrently, growing demand for more predictive in vitro models has elevated the importance of co-culture capabilities and tri-dimensional constructs, prompting insert manufacturers to innovate around compatibility with extracellular matrix components and cell-derived scaffolds. Regulatory agencies and safety scientists are increasingly receptive to data generated from well-characterized insert-based assays, catalyzing adoption in preclinical safety and toxicology workflows. At the same time, contract research organizations are standardizing insert-based protocols to improve throughput and client confidence, which drives the need for consistent quality and robust supplier relationships.

Operationally, supply chain resilience and quality management systems now factor into competitive differentiation. Manufacturers that can demonstrate rigorous material traceability, lot-to-lot consistency, and validated cleaning or sterilization processes are favored by enterprise buyers. Taken together, these shifts are reshaping how end users assess value, encouraging a shift from transactional purchasing toward partnership models that prioritize performance, validation support, and long-term collaboration.

Tariff-driven supply chain realignment is compelling manufacturers and procurement teams to prioritize localization, alternative sourcing, and continuity planning

The tariff environment in the United States has introduced a layer of complexity for producers, distributors, and end users of porous cell culture inserts, influencing cost structures and sourcing strategies. Tariff actions change the relative economics of importing finished inserts or component raw materials, prompting many organizations to reevaluate supplier footprints and to consider nearshoring or multi-sourcing approaches to mitigate exposure. In practice, procurement teams are balancing the need for technical specifications with the imperative to secure consistent supply at acceptable landed costs.

As a result of tariff-driven cost pressures, some manufacturers have accelerated their efforts to localize production, invest in domestic contract manufacturing partnerships, or reconfigure product lines to rely on alternative raw materials that are not subject to the same tariff classifications. These tactical responses aim to preserve competitive pricing while maintaining performance attributes that researchers require. Meanwhile, distributors and service providers are offering more flexible purchasing terms and inventory solutions to smooth short-term volatility and to protect research timelines.

For laboratories and research organizations, the practical implication is that lead times and procurement complexity may increase, necessitating stronger communication between scientific teams and supply chain managers. In response, scientific leaders are formalizing specifications and establishing contingency plans that prioritize continuity of critical assays. Ultimately, tariff-induced shifts are stimulating strategic realignment across the value chain, emphasizing supply resilience and technical continuity over short-term price optimization.

Detailed segmentation reveals how membrane composition, pore architecture, format configuration, end user needs, and application demands jointly determine procurement choices

A granular view of the product space reveals clear distinctions that influence purchasing behavior and experimental outcomes. When membrane material is considered, polycarbonate membranes offer optical clarity and structural stability; polyethylene terephthalate brings improved chemical compatibility for certain assays; polysulfone is selected for its robustness under sterilization regimes; and polyvinylidene fluoride delivers high protein binding resistance for specified applications. These material choices are commonly matched to the assay chemistry, sterilization approach, and imaging requirements that define a laboratory's protocols.

Pore size is another defining attribute that governs cell migration, nutrient exchange, and paracellular transport. Categories span very small pores that restrict cell passage yet permit solute diffusion, intermediate ranges optimized for barrier and transport studies with subdivisions that capture 0.4 to one micrometer and one to three micrometers for nuanced cell-permeability profiles, and larger pores that support transmigration and scaffold integration. Selecting the appropriate pore architecture requires alignment with cell type, co-culture objectives, and endpoint measurements.

Insert format is often dictated by throughput needs and compatibility with existing labware; options range from formats designed for six-well plates to those tailored for twelve-well setups and higher-density twenty-four-well configurations. End users vary across academic and research institutes that prioritize methodological flexibility, contract research organizations that emphasize standardized throughput, and pharmaceutical and biotechnology companies that demand validated performance for regulated studies. Application-driven distinctions further refine selection: drug discovery workflows leverage inserts for ADME testing and high-throughput screening where reproducibility and assay miniaturization are valued, regenerative medicine applications prioritize scaffold compatibility and cell-matrix interactions, while toxicology requires validated barrier integrity metrics and assay robustness. These intersecting segmentation vectors create a decision matrix that manufacturers and buyers must navigate to align product attributes with scientific objectives and operational constraints.

Regional research intensity, regulatory diversity, and manufacturing footprints are shaping demand priorities and supplier selection across global markets

Geographic dynamics shape both demand patterns and supply considerations across the porous insert market. In the Americas, a dense concentration of pharmaceutical and biotechnology companies, together with well-funded academic research centers, sustains demand for high-performance inserts with tight validation and quality expectations. This region also exhibits strong activity in contract research organizations that standardize insert-based workflows to support global clients, creating an ecosystem that favors suppliers who offer reliable documentation, regulatory alignment, and responsive technical support.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory frameworks, research funding models, and clinical priorities vary substantially between markets. Western Europe tends to prioritize advanced in vitro models and sustainability credentials, while emerging markets within the region are focused on access and cost-effectiveness. Manufacturers that navigate regional certification requirements and local distributor networks are positioned to capture diversified demand across academia, CROs, and industry players.

Asia-Pacific demonstrates rapid growth in research capacity, with significant investment in both basic science and industrial R&D across several countries. The region's scale and manufacturing capabilities also make it a critical node in global supply chains, influencing pricing dynamics and lead time expectations. Across all regions, buyers increasingly evaluate supplier transparency, quality systems, and supply resilience as decisive procurement criteria, and regional differences often dictate how those criteria are weighted relative to price and innovation.

Innovation-focused firms differentiate through validated materials, scalable manufacturing, and collaborative validation pathways to win demanding scientific customers

Competitive dynamics in the porous insert arena are driven by product differentiation, quality assurance, and the ability to scale production while maintaining strict material traceability. Leading companies that capture sustained buyer confidence typically invest heavily in R&D to refine membrane properties and to expand format compatibility with automated and high-content imaging platforms. These firms also emphasize robust quality management systems, enabling them to supply validated products that integrate into regulated workflows used by pharmaceutical and biotechnology customers.

Strategic partnerships and targeted acquisitions are common as companies seek to broaden their technical portfolios and to secure supply chain advantages. Collaboration between manufacturers and academic laboratories often accelerates product refinement and validation, creating a pathway for rapid adoption in specialized applications such as barrier integrity assays and regenerative medicine constructs. At the same time, smaller niche players differentiate themselves through specialized materials, bespoke manufacturing runs, or highly responsive technical support that appeals to demanding research programs.

From an operational perspective, investments in scalable manufacturing capacity, cleanroom certifications, and sterilization validation have become competitive imperatives. Companies that provide comprehensive documentation, sample support, and application notes gain preference among enterprise buyers. Finally, the ability to offer configurable kits or OEM partnerships for instrument compatibility continues to be a strong driver of commercial traction, aligning supplier capabilities with evolving laboratory ecosystems.

Practical strategic moves for manufacturers and suppliers to secure resilience, validate performance, and deepen customer relationships with application-driven offerings

Industry leaders should prioritize a set of pragmatic actions to secure competitive advantage while supporting end-user needs. First, align product development with demonstrable assay performance by investing in independent validation studies and publishing application notes that map material attributes to experimental outcomes. This evidence-based approach reduces buyer friction and accelerates adoption across research and regulated environments.

Second, strengthen supply chain resilience by diversifying supplier bases for key raw materials, qualifying secondary manufacturing sites, and establishing safety-stock policies in collaboration with major customers. Doing so protects research timelines and reduces the operational risk associated with trade policy volatility. Third, expand technical support offerings by creating modular training packages, protocol repositories, and rapid-response troubleshooting services that help users integrate inserts into automated and high-content workflows with confidence.

Fourth, pursue targeted partnerships with instrument manufacturers, reagent suppliers, and contract research organizations to create integrated solutions that reduce adoption barriers for end users. Fifth, adopt sustainable manufacturing practices and transparent material sourcing as differentiators that meet evolving procurement criteria in academia and industry. Finally, implement flexible commercial models that include trial programs, tiered licensing, and co-development arrangements to lower the threshold for enterprise evaluation and to accelerate long-term partnerships.

A mixed-methods approach combining primary stakeholder interviews, peer-reviewed literature review, and iterative validation to ensure rigorous and practice-oriented insights

The research methodology for this analysis combined qualitative and quantitative techniques to ensure a comprehensive and verifiable understanding of trends, user requirements, and supplier dynamics. Primary research consisted of structured interviews with laboratory directors, procurement leads within pharmaceutical and biotech organizations, senior scientists at contract research organizations, and operations leaders at manufacturing firms. These conversations focused on procurement criteria, assay validation needs, supply chain considerations, and the operational impact of regulatory and tariff developments.

Secondary research included an in-depth review of peer-reviewed literature, technical white papers, manufacturer product specifications, regulatory guidance documents, and patent activity to triangulate technological trajectories and performance attributes. Where appropriate, product data sheets and validation reports were analyzed to compare material properties, pore architectures, and format compatibility. Data synthesis prioritized corroborated evidence and cross-checked vendor claims with independent usage feedback.

Analytical rigor was maintained through iterative hypothesis testing, sensitivity checks, and peer review by subject-matter experts. Limitations of the methodology are acknowledged: primary interviews reflect the perspectives of a subset of stakeholders and may emphasize current operational challenges, while secondary sources vary in granularity and focus. To mitigate these constraints, findings were validated across multiple respondent types and through cross-referencing of independent documentation, resulting in a robust, practitioner-oriented evidence base for the insights presented.

Synthesizing technical attributes, supply continuity, and validation pathways to align product selection with experimental objectives and operational resilience

Porous cell culture inserts occupy a pivotal place in contemporary life sciences workflows by enabling more physiologically relevant experiments without imposing undue complexity on laboratory operations. Material selection, pore architecture, and format compatibility remain the primary determinants of product suitability, and these technical attributes are increasingly assessed through the lens of reproducibility and regulatory acceptability. Meanwhile, supply chain dynamics and tariff considerations are prompting manufacturers and buyers to re-evaluate sourcing strategies and to prioritize resilience alongside performance.

The confluence of rising demand for predictive in vitro models, increased emphasis on validated methods in safety testing, and the maturation of automated laboratory systems suggests that insert suppliers who can combine technical excellence with dependable delivery and strong application support will be best positioned to capture long-term customer loyalty. Strategic investments in validation studies, manufacturing scalability, and integrated solution partnerships will accelerate market traction and reduce barriers to adoption for enterprise clients.

In closing, stakeholders that approach product selection and procurement through a holistic framework-balancing material science, assay requirements, supply continuity, and end-user support-will achieve clearer alignment between scientific objectives and operational execution. This balanced approach facilitates robust experimental outcomes while de-risking programmatic timelines and enabling deeper collaboration across the research ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Porous Cell Culture Inserts Market, by Membrane Material

  • 8.1. Polycarbonate
  • 8.2. Polyethylene Terephthalate
  • 8.3. Polysulfone
  • 8.4. Polyvinylidene Fluoride

9. Porous Cell Culture Inserts Market, by Pore Size

  • 9.1. 0.4 To Three Micrometers
    • 9.1.1. 0.4 To One Micrometer
    • 9.1.2. One To Three Micrometers
  • 9.2. Greater Than Three Micrometers
  • 9.3. Less Than 0.4 Micrometers

10. Porous Cell Culture Inserts Market, by Insert Format

  • 10.1. Six Well
  • 10.2. Twelve Well
  • 10.3. Twenty Four Well

11. Porous Cell Culture Inserts Market, by Application

  • 11.1. Drug Discovery
    • 11.1.1. ADME Testing
    • 11.1.2. High Throughput Screening
  • 11.2. Regenerative Medicine
  • 11.3. Toxicology

12. Porous Cell Culture Inserts Market, by End User

  • 12.1. Academic And Research Institutes
  • 12.2. Contract Research Organizations
  • 12.3. Pharmaceutical And Biotechnology Companies

13. Porous Cell Culture Inserts Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Porous Cell Culture Inserts Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Porous Cell Culture Inserts Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Porous Cell Culture Inserts Market

17. China Porous Cell Culture Inserts Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Becton, Dickinson and Company
  • 18.6. BRAND GmbH + Co KG
  • 18.7. CELLTREAT Scientific Products, LLC
  • 18.8. Corning Incorporated
  • 18.9. Eppendorf AG
  • 18.10. Greiner Bio-One International GmbH
  • 18.11. Merck KGaA
  • 18.12. Sartorius AG
  • 18.13. STEMCELL Technologies Inc.
  • 18.14. Techno Plastic Products AG
  • 18.15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POROUS CELL CULTURE INSERTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POROUS CELL CULTURE INSERTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYETHYLENE TEREPHTHALATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYSULFONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYSULFONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYSULFONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY POLYVINYLIDENE FLUORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO ONE MICROMETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO ONE MICROMETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO ONE MICROMETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ONE TO THREE MICROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ONE TO THREE MICROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ONE TO THREE MICROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY GREATER THAN THREE MICROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY GREATER THAN THREE MICROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY GREATER THAN THREE MICROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY LESS THAN 0.4 MICROMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY LESS THAN 0.4 MICROMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY LESS THAN 0.4 MICROMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY SIX WELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY SIX WELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY SIX WELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TWELVE WELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TWELVE WELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TWELVE WELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TWENTY FOUR WELL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TWENTY FOUR WELL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TWENTY FOUR WELL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ADME TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ADME TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ADME TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY REGENERATIVE MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY REGENERATIVE MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TOXICOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY TOXICOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 147. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 148. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 171. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 172. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 179. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 180. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL POROUS CELL CULTURE INSERTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY MEMBRANE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY 0.4 TO THREE MICROMETERS, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY INSERT FORMAT, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA POROUS CELL CULTURE INSERTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)